Halozyme Therapeutics, Inc. logo HALO - Halozyme Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 17
HOLD 9
SELL 1
STRONG
SELL
0
| PRICE TARGET: $75.00 DETAILS
HIGH: $95.00
LOW: $56.00
MEDIAN: $75.00
CONSENSUS: $75.00
UPSIDE: 9.78%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Revenue
Revenue 1,396.6 1,015.3 829.3 660.1 443.3 267.6 196.0 151.9 316.6 146.7 135.1 75.3 54.8 42.3 56.1 13.6 13.7 8.8 3.8 1.0 0.1 0 0.0 0.1 0.0
Cost of Revenue 305.4 159.4 192.4 139.3 81.4 43.4 45.5 10.1 31.2 33.2 29.2 22.7 6.2 1.1 0.3 1.0 0.3 0.3 0.2 0.4 0.1 0 0.0 0.0 0.0
Gross Profit 1,091.2 855.9 636.9 520.8 361.9 224.2 150.4 141.7 285.5 113.5 105.8 52.6 48.6 41.2 55.8 12.6 13.4 8.4 3.6 0.5 0.1 0 (0.0) 0.0 0.0
Operating Expenses
R&D Expenses 81.5 79.0 76.4 66.6 35.7 34.2 140.8 150.3 150.6 150.8 93.2 79.7 96.6 70.0 57.6 51.8 56.6 44.2 20.6 9.2 10.2 6.5 0 0 0
SG&A Expenses 193.4 154.3 149.2 143.5 50.3 45.7 77.3 60.8 53.8 45.9 40.0 35.9 32.3 24.8 18.1 15.1 15.2 14.6 11.2 6.9 3.4 2.6 0.1 0.0 0.0
Other Expenses 0 71.0 73.8 43.1 0 0 0 0 0 0 0 0 0 0.0 0 0 0 0 0 0 0 0 0 0.1 0
Operating Expenses 274.9 304.4 299.3 253.3 86.0 80.0 218.1 211.1 204.5 196.7 133.3 115.6 129.0 94.9 75.7 66.9 71.8 58.9 31.7 16.1 13.6 9.1 0.1 0.1 0.0
Operating Income
Operating Income 816.3 551.5 337.6 267.5 275.9 144.3 (67.6) (69.3) 81.0 (83.2) (27.5) (63.0) (80.4) (53.6) (19.8) (54.3) (58.5) (50.4) (28.2) (15.6) (13.6) (9.1) (0.1) (0.0) (0.0)
Interest Expense 18.1 18.1 18.8 16.9 7.5 20.4 11.6 18.0 22.0 20.0 5.2 5.6 3.3 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0.0 0.1 1.7 0 0 0 0 0 0 0
Profitability
EBITDA 904.3 656.5 451.9 315.5 259.0 153.0 (56.6) (69.3) 83.2 (79.5) (25.4) (61.0) (79.0) (52.5) (18.7) (52.7) (56.9) (49.4) (28.2) (14.5) (13.4) (9.0) (0.1) (0.0) (0.0)
EBIT 816.3 575.2 367.1 265.9 256.0 149.7 (60.6) (69.3) 81.0 (81.9) (27.0) (62.8) (80.2) (53.6) (19.8) (54.3) (58.5) (50.4) (28.2) (15.6) (13.6) (9.1) 0 (0.0) (0.0)
Income Before Tax 466.9 557.1 348.3 248.9 248.5 129.3 (72.3) (79.8) 61.6 (101.9) (32.2) (68.4) (83.5) (53.6) (19,769.9) (53.2) (58.4) (48.7) 0 0 (13.3) (9.1) 0 (0.1) (0.0)
Income Tax Expense 150.0 113.0 66.7 46.8 (154.2) 0.2 (0.0) 0.5 (1.4) 1.2 0 0 2.0 (1.1) (1.2) 0 0 (0.1) (4.3) (0.8) 0 0.0 0.1 0.0 0
Net Income 316.9 444.1 281.6 202.1 402.7 129.1 (72.2) (80.3) 63.0 (103.0) (32.2) (68.4) (83.5) (53.6) (19.8) (53.2) (58.4) (48.7) (23.9) (14.8) (13.3) (9.1) (0.1) (0.1) (0.0)
Per Share Data
EPS (Basic) 2.64 3.50 2.13 1.48 2.86 0.95 -0.50 -0.56 0.46 -0.81 -0.25 -0.56 -0.74 -0.48 -0.19 -0.56 -0.67 -0.61 -0.32 -0.24 -0.26 -0.26 -0.01 -0.01 -0.03
EPS (Diluted) 2.56 3.43 2.10 1.44 2.74 0.91 -0.50 -0.56 0.45 -0.81 -0.25 -0.56 -0.74 -0.48 -0.19 -0.56 -0.67 -0.61 -0.32 -0.24 -0.26 -0.26 -0.01 -0.01 -0.03
Shares Outstanding 119.8 126.8 131.9 136.8 140.6 136.2 144.3 143.4 136.4 127.2 126.7 122.7 112.8 111.1 102.6 94.4 86.7 79.8 74.3 62.6 50.3 35.4 6.8 4.6 1.2
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004 2003 2002 2001
Current Assets
Cash & Cash Equivalents 133.8 115.8 118.4 234.2 118.7 147.7 120.2 57.9 168.7 66.8 67.5 63.7 16.0 0.0 0.1 0.0
Short-Term Investments 9 480.2 217.6 128.6 622.2 220.3 301.1 296.6 300.5 138.2 0 0 0 0 0 0
Net Receivables 441.3 308.5 234.2 231.1 91.0 97.7 59.4 30.0 22.1 15.7 4.2 7.3 0 0 0 0
Inventory 176.5 141.9 127.6 100.1 53.9 60.7 29.4 22.6 5.1 14.6 1.2 0.4 0.1 0 0 0
Other Current Assets 64.6 39.0 48.6 45.0 0 0 0 0 0 0 0 0 0 (0.5) 0 0
Total Current Assets 825.2 1,085.3 746.4 739.0 926.3 554.8 543.4 427.8 510.4 256.5 74.4 74.0 16.1 0.0 0.1 0.0
Non-Current Assets
Property, Plant & Equipment 82.1 75.0 74.9 75.6 8.8 10.6 10.9 7.5 3.5 4.3 2.7 2.5 0.2 0 0 0
Goodwill 580.4 416.8 416.8 409.0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 981.5 401.8 472.9 546.7 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 56.2 80.6 17.8 26.8 13.9 14.6 11.6 4.9 6.1 0.7 0 0 0.0 0 0 0
Total Non-Current Assets 1,700.1 978.1 986.8 1,102.5 178.1 25.2 22.4 12.4 9.6 5.0 2.7 2.5 0.3 0 0 0
Total Assets 2,525.3 2,063.5 1,733.3 1,841.5 1,104.4 579.9 565.9 440.2 519.9 261.5 77.1 76.6 16.4 0.0 0.1 0.0
Current Liabilities
Account Payables 20.9 10.2 11.8 17.7 1.5 1.9 6.4 4.1 7.9 3.6 2.8 6.7 1.5 0.0 0 0
Short-Term Debt 0 0 0 13.3 89.4 397.2 19.5 91.5 77.2 17.4 0 0 0 0 0 0
Deferred Revenue 0 0 0 3.2 1.7 1.7 4.0 4.2 6.6 4.8 5.5 3.6 0 0 0 0
Other Current Liabilities 156.2 0 0 (3.2) 0 0 0 0 0 0 0 0 0 0 0.0 0.0
Total Current Liabilities 177.1 139.1 112.5 130.8 117.1 421.4 85.6 149.4 131.3 54.6 14.4 14.2 1.6 0.0 0.0 0.0
Non-Current Liabilities
Long-Term Debt 2,142.6 1,505.8 1,499.2 1,492.8 787.3 0 383.0 34.9 125.1 199.2 0 0 0 0 0 0
Deferred Tax Liabilities 42.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 113.9 54.8 37.7 45.9 0.5 3.5 4.2 2.1 0.8 0.4 0.9 1.1 0 0 0 0
Total Non-Current Liabilities 2,299.4 1,560.6 1,537.0 1,540.9 790.3 7.5 388.5 42 180.3 239.4 55.8 47.0 0 0 0 0
Total Liabilities 2,476.5 1,699.7 1,649.5 1,671.7 907.5 428.9 474.1 191.4 311.6 294.0 70.2 61.2 1.6 0.0 0.0 0.0
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0
Retained Earnings 54.8 359.9 90.5 143.2 (58.9) (474.6) (603.7) (531.4) (522.4) (585.3) (172.0) (113.6) (13.1) (0.2) (0.1) (0.0)
Accumulated Other Comprehensive Income (18.1) 3.8 (9.3) (0.9) (0.6) 0.0 0.2 (0.3) (0.5) (0.0) (3.4) (2.0) (0.3) 0 0 0
Total Stockholders' Equity 48.8 363.8 83.8 169.8 197.0 151.0 91.8 248.9 208.4 (32.5) 6.9 15.4 14.8 0.0 0.1 0.0
Total Liabilities & Equity 2,525.3 2,063.5 1,733.3 1,841.5 1,104.4 579.9 565.9 440.2 519.9 261.5 77.1 76.6 16.4 0.0 0.1 0.0
Debt Metrics
Total Debt 2,142.6 1,505.8 1,499.2 1,506.1 876.7 397.2 402.6 126.4 202.4 216.6 0 0 0 0 0 0
Net Debt 2,008.8 1,389.9 1,380.9 1,271.9 758.0 249.5 282.4 68.4 33.6 149.9 (67.5) (63.7) (16.0) (0.0) (0.1) (0.0)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004 2003 2002 2001
Operating Activities
Net Income 316.9 444.1 281.6 202.1 402.7 129.1 (72.2) (80.3) 63.0 (103.0) (13.3) (9.1) (0.1) (0.1) (0.0)
Depreciation & Amortization 88.1 88.7 84.9 57.5 6.6 17.4 6.6 2.4 2.2 2.4 0.2 0.1 0 0 0
Stock-Based Compensation 51.6 43.4 36.6 24.4 20.8 17.2 34.8 35.7 30.7 25.6 0 0 0 0 0
Change in Working Capital (152.3) (136.3) (38.7) (110.5) 2.6 (67.2) (55.2) (5.9) 20.7 17.0 (0.1) 1.2 0.0 0.0 0.0
Other Non-Cash Items 346.7 39.2 (10.3) 66.6 (133.3) (41.1) 0.7 1.7 17.8 7.1 0.2 0.1 0.0 0.0 0.0
Operating Cash Flow 651.6 479.1 388.6 240.1 299.4 55.5 (85.4) (49.5) 134.1 (50.4) (13.0) (7.7) (0.0) (0.1) (0.0)
Investing Activities
Capital Expenditure (7.0) (10.7) (15.3) (4.8) (1.5) (2.5) (4.0) (4.7) (1.4) (3.1) (0.4) (0.2) 0 0 0
Acquisitions (726.0) 0 0 (999.1) 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (247.4) 0 (292.9) 0 0 0 0 (311.1) (398.2) (155.4) 0 0 0 0 0
Sales/Maturities of Investments 722.2 0 211.3 0 0 0 0 318.3 235.8 81.8 0 0 0 0 0
Other Investing Activities (287.8) (252.0) 0 516.9 (404.8) 80.9 (1.5) 7.2 (162.4) (73.6) 0 0 0 0 0
Investing Cash Flow (545.8) (262.7) (96.9) (487.0) (406.3) 78.4 (5.5) 2.5 (163.7) (76.8) (0.4) (0.2) 0 0 0
Financing Activities
Net Debt Issuance 235.4 0 (13.5) 624.5 415.8 (19.6) 339.3 (77.5) (16.0) 148.8 0 0 0 0 0
Stock Repurchased (342.4) (250) (402.4) (200.0) (350.1) (150.1) (200.0) 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 31.1 7.9 (62.2) 12.1 63.4 13.9 13.7 12.8 1.9 0 7.9 0 0 0
Financing Cash Flow (85.2) (218.9) (408.0) 362.4 77.9 (106.3) 153.2 (63.8) 131.7 150.6 16.5 23.4 0 0.1 0.1
Cash Position
Net Change in Cash 20.6 (2.5) (116.3) 115.5 (29.0) 27.5 62.2 (110.8) 102.0 23.5 3.1 15.5 (0.0) 0.1 0.0
Cash at Beginning 115.8 118.4 234.7 119.2 148.2 120.7 58.4 169.2 67.3 43.3 16.0 0.5 0.1 0.0 0
Cash at End 136.4 115.8 118.4 234.7 119.2 148.2 120.7 58.4 169.2 66.8 19.1 16.0 0.0 0.1 0.0
Free Cash Flow 644.6 468.4 373.3 235.3 298.0 53.0 (89.5) (54.2) 132.7 (53.5) (13.3) (7.9) (0.0) (0.1) (0.0)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
Income Statement
Revenue 1,396.6 1,015.3 829.3 660.1 443.3 267.6 196.0 151.9 316.6 146.7 135.1 75.3 54.8 42.3 56.1 13.6 13.7 8.8 3.8 1.0 0.1 0 0.0 0.1 0.0
Gross Profit 1,091.2 855.9 636.9 520.8 361.9 224.2 150.4 141.7 285.5 113.5 105.8 52.6 48.6 41.2 55.8 12.6 13.4 8.4 3.6 0.5 0.1 0 (0.0) 0.0 0.0
Operating Income 816.3 551.5 337.6 267.5 275.9 144.3 (67.6) (69.3) 81.0 (83.2) (27.5) (63.0) (80.4) (53.6) (19.8) (54.3) (58.5) (50.4) (28.2) (15.6) (13.6) (9.1) (0.1) (0.0) (0.0)
Net Income 316.9 444.1 281.6 202.1 402.7 129.1 (72.2) (80.3) 63.0 (103.0) (32.2) (68.4) (83.5) (53.6) (19.8) (53.2) (58.4) (48.7) (23.9) (14.8) (13.3) (9.1) (0.1) (0.1) (0.0)
EPS (Diluted) 2.56 3.43 2.10 1.44 2.74 0.91 -0.50 -0.56 0.45 -0.81 -0.25 -0.56 -0.74 -0.48 -0.19 -0.56 -0.67 -0.61 -0.32 -0.24 -0.26 -0.26 -0.01 -0.01 -0.03
Balance Sheet
Cash & Equivalents 133.8 115.8 118.4 234.2 118.7 147.7 120.2 57.9 168.7 66.8 67.5 63.7 16.0 0.0 0.1 0.0
Total Assets 2,525.3 2,063.5 1,733.3 1,841.5 1,104.4 579.9 565.9 440.2 519.9 261.5 77.1 76.6 16.4 0.0 0.1 0.0
Total Debt 2,142.6 1,505.8 1,499.2 1,506.1 876.7 397.2 402.6 126.4 202.4 216.6 0 0 0 0 0 0
Stockholders' Equity 48.8 363.8 83.8 169.8 197.0 151.0 91.8 248.9 208.4 (32.5) 6.9 15.4 14.8 0.0 0.1 0.0
Cash Flow
Operating Cash Flow 651.6 479.1 388.6 240.1 299.4 55.5 (85.4) (49.5) 134.1 (50.4) (13.0) (7.7) (0.0) (0.1) (0.0)
Capital Expenditure (7.0) (10.7) (15.3) (4.8) (1.5) (2.5) (4.0) (4.7) (1.4) (3.1) (0.4) (0.2) 0 0 0
Free Cash Flow 644.6 468.4 373.3 235.3 298.0 53.0 (89.5) (54.2) 132.7 (53.5) (13.3) (7.9) (0.0) (0.1) (0.0)